Prudent Man Advisors, LLC Astrazeneca PLC Transaction History

Prudent Man Advisors, LLC

$295 Million
Q3 2024

A detailed history of Prudent Man Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Prudent Man Advisors, LLC holds 3,110 shares of AZN stock, worth $200,408. This represents 0.08% of its overall portfolio holdings.

Number of Shares

3,110

Previous 3,094 0.52%

Holding current value

$200,408

Previous $241,000 0.41%

% of portfolio

0.08%

Previous 0.09%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$76.67 - $87.62 $1,226 - $1,401	16 Added 0.52%	3,110 $242,000
Q1 2024 May 14, 2024	SELL	$61.03 - $69.57 $40,707 - $46,403	-667 Reduced 17.73%	3,094 $209,000
Q4 2023 Feb 13, 2024	SELL	$61.89 - $69.28 $10,583 - $11,846	-171 Reduced 4.35%	3,761 $253,000
Q3 2023 Nov 09, 2023	SELL	$64.85 - $71.7 $8,495 - $9,392	-131 Reduced 3.22%	3,932 $266,000
Q4 2022 Feb 13, 2023	BUY	$54.21 - $70.44 $220,255 - $286,197	4,063 New	4,063 $275,000
Q2 2022 Aug 05, 2022	SELL	$59.26 - $71.14 $187,498 - $225,086	-3,164 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$55.72 - $67.12 $176,298 - $212,367	3,164 New	3,164 $210,000
Q4 2021 Feb 10, 2022	SELL	$54.02 - $63.83 $208,247 - $246,064	-3,855 Closed	0 $0
Q2 2021 Aug 03, 2021	BUY	$48.42 - $60.18 $186,659 - $231,993	3,855 New	3,855 $231,000
Q4 2020 Feb 11, 2021	SELL	$48.52 - $58.02 $181,028 - $216,472	-3,731 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$53.07 - $61.1 $3,184 - $3,666	-60 Reduced 1.58%	3,731 $204,000
Q2 2020 Aug 12, 2020	BUY	$43.1 - $55.31 $163,392 - $209,680	3,791 New	3,791 $201,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudent Man Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prudent Man Advisors, LLC with notifications on news.

Account

Prudent Man Advisors, LLC Astrazeneca PLC Transaction History